Reuters logo
BRIEF-Lannett receives approval for Dexmethylphenidate Hydrochloride tablets, 2.5 mg, 5 mg and 10 mg
September 26, 2017 / 11:13 AM / a month ago

BRIEF-Lannett receives approval for Dexmethylphenidate Hydrochloride tablets, 2.5 mg, 5 mg and 10 mg

Sept 26 (Reuters) - Lannett Company Inc

* Lannett receives approval for Dexmethylphenidate Hydrochloride tablets, 2.5 mg, 5 mg and 10 mg

* Lannett Company Inc - ‍Anticipates launching Dexmethylphenidate Hydrochloride tablets in next several months​

* Lannett Company Inc - ‍Dexmethylphenidate Hydrochloride tablets are used for treatment of attention deficit and hyperactivity disorder ​ Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below